Last reviewed · How we verify

NCT03989076

Inferior Vena Cava (IVC) Diameters Before & After Interscalene Block

Withdrawn Last updated 21 July 2021
What this trial tests

trial testing Interscalene Brachial Plexus Block in IVC - Inferior Vena Cava Abnormality. Withdrawn.

Timeline
12 April 2019
Primary endpoint
14 July 2021
14 July 2021

Quick facts

Lead sponsorUniversity of California, San Diego
StatusWithdrawn
Study typeOBSERVATIONAL
Start date12 April 2019
Primary completion14 July 2021
Estimated completion14 July 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Diego

Who can join

18 and older, any sex, with IVC - Inferior Vena Cava Abnormality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to understand how changes to breathing patterns in the chest affect blood flow to the heart from the inferior vena cava in the abdomen. Ultrasound of the upper abdomen will be used to visualize changes in breathing patterns in the chest and blood flow in the abdomen.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Interscalene Brachial Plexus Block

Trials testing the same drug.

Other University of California, San Diego trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03989076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing